Efficacy and Safety of Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules: A Long-Term Prospective Study
Dang Luu Vu,Minh Thong Pham,Van Bang Nguyen,Thi My Le
DOI: https://doi.org/10.2147/TCRM.S344464
2022-01-06
Therapeutics and Clinical Risk Management
Abstract:Dang Luu Vu, 1 Minh Thong Pham, 1 Van Bang Nguyen, 2 Thi My Le 3 1 Bach Mai Radiology Center, Bach Mai Hospital, Hanoi, Vietnam; 2 Center of Endocrinology and Diabetes, Family Hospital, Da Nang, Vietnam; 3 Radiology Department, Vinmec Times City International Hospital, Hanoi, Vietnam Correspondence: Thi My Le Radiology Department, Vinmec Times City International Hospital, Hanoi, Vietnam Tel +84 979600233 Email Objective: This study aims to evaluate the efficacy and safety of RFA in the AFTN treatment after 2 years of follow-up and to find the factors related to treatment responses through TSH level and VRR. Materials and Methods: This long-term prospective study was conducted from September 2017 to April 2021 on 17 AFTNs treated with RFA. Clinical evaluations, thyroid function tests, thyroid scintigraphy, and ultrasonography examinations were performed at 1 month, 3 months, 6 months, and 24 months after ablation. The primary endpoint was the success rate of RFA in restoring the euthyroidism stage after 24 months of follow-ups; secondary outcomes were VRR and improvements of US parameters, clinical examinations, and complications. The Spearman rank correlation test was used to determine related factors with treatment response variables. Results: At the 24 months after the procedure, symptom score, cosmetic score, vascularity grade, and nodule volume significantly decreased. The VRR reduced approximately 42.77%, 63.13%, 78.3%, and 95.65% after 1 month, 3 months, 6 months, and 24 months follow-up. All 17 patients were restored euthyroid state without taking ATDs. No major complications were collected. The last TSH level was significantly correlated with the age of patients (Spearman rho = − 0.637, p = 0.008). The VRR was significantly correlated with age of patients (Spearman rho = 0.566, p = 0.018) and initial TSH (Spearman rho = 0.485, p = 0.048). Conclusion: RFA was demonstrated as a safe and effective option for AFTN treatment in long-term follow-up. It can be used as an alternative treatment with encouraging results. Keywords: radiofrequency ablation, thyroid nodules, autonomously functioning thyroid nodule The autonomously functioning thyroid nodule (AFTN), the prevalence from 0.9% up to 9% of all thyroid nodules, is a predominantly benign neoplasm presenting as a solitary hyperfunctioning nodule, inside healthy thyroid parenchyma. 1,2 Because of the strong concentration of Iodine-131 or 99mTc used as a radiotracer (dose, 50 μCi of Iodine-131) by thyroid scintigraphy, it can be seen as a "hot spot", different from the surrounding thyroid tissue. AFTNs can cause functional abnormalities, from euthyroidism to subclinical hyperthyroidism (pre-toxic nodule) and overt hyperthyroidism (toxic nodule). 3 Thus, after confirming benign thyroid nodule(s), treatment decisions usually depend on the presence of nodule-related clinical hyperthyroidism symptoms, compressive and/or cosmetic issues. 4–8 In worldwide and Vietnam, anti-thyroid drugs (ATDs), thyroid lobectomy, or radioiodine (RI) treatment are preferred for treating AFTNs but both have limitations. ATDs decrease thyroid hormone production in the short term and are not effective in the long term. 9 The disadvantage of surgery is a high risk of general anesthesia, secondary hypothyroidism, and ugly scar. Using RI treatment often requires a second treatment session because of the higher risk of failure after the first session by large nodules. Also, young women of child-bearing age and patients who can stand living with hypothyroidism may not be suitable with this therapy. In addition, another disadvantage is radiation exposure. 10–13 In the last few years, radiofrequency ablation (RFA) has been rising from a new treatment way of symptomatic thyroid nodule(s) as a minimally invasive procedure. It has been used for the treatment of not only non-functional benign thyroid nodules but also AFTNs according to recent guidelines. 6,14,15 However, the efficacy of RFA on AFTNs is highly fluctuating in the rate of thyroid function normalization (24–82%) and in the volume reduction rate (VRR) >50%. 16–22 In Vietnam, RFA has been applied for benign thyroid nodules since 2016. Thus, a few studies about the safety and efficacy of RFA for benign thyroid nodules were available and no study demonstrated its efficacy on AFTNs. 23,24 Therefore, our study aims to evaluate the efficacy and safety of RFA in the AFTN treatment after 2 years of follow-up and to find the factors related to treatment responses through TSH level and VRR. This study was conducted in accordance with the Declaration of Helsinki. The Ethics Committee of the In -Abstract Truncated-
health care sciences & services